Company Filing History:
Years Active: 2023-2025
Title: Damien Patrick Flynn: Innovator in Pediatric Pharmaceutical Formulations
Introduction
Damien Patrick Flynn is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of pharmaceuticals, particularly in pediatric formulations. With a total of 2 patents, Flynn's work focuses on improving the delivery and effectiveness of medications for children.
Latest Patents
Flynn's latest patents include innovative pediatric suspension formulations. These formulations relate to storage-stable proton pump inhibitor (PPI) systems that comprise a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole. The formulations are designed to be constituted with water prior to administration, ensuring stability and efficacy. Additionally, they include oral pharmaceutical suspensions that consist of water, a therapeutically effective amount of a PPI, and one or more buffering agents.
Career Highlights
Damien Flynn is currently associated with Xeolas Pharmaceuticals Ltd., where he continues to develop groundbreaking pharmaceutical solutions. His expertise in pediatric formulations has positioned him as a key player in the industry, contributing to advancements that enhance the quality of care for young patients.
Collaborations
Flynn has collaborated with notable colleagues, including Dennis Mark McDaid and Maurice Joseph Anthony Clancy. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Damien Patrick Flynn's contributions to pediatric pharmaceutical formulations demonstrate his commitment to improving healthcare for children. His innovative patents and collaborations highlight his role as a leading inventor in the pharmaceutical industry.